NXP-2P2005162026-04 — Nexaph Tirzepatide
Independently TestedNexaph | Tirzepatide, last activity 2 hours ago
2 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 20 mg. Janoshik weighed 23 mg — 15% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
17 units
on a U-100 insulin syringe, for 2 mg
Going by the label you would draw 20 units — which from this vial is actually 2.3 mg, not 2 mg.
- The vial holds dry powder: 23 mg of Tirzepatide, as weighed.
- Water spreads that powder evenly through the liquid: 23 mg ÷ 2 ml = 11.5 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 115 mcg.
- Your dose divided by that: 2 mg ÷ 115 mcg = 17 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
same lot series
also Nexaph
Adamax, same vendor
1 community mention, no summary yet
GYC/GGpeps
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
Community Intelligence
- 1 concern report involving 2026061030
- 2 concern reports involving SN26XY-1-02
Reported against other Nexaph Tirzepatide batches, not this one.
Also known as: NXP2P200516202604
Activity
No community activity tracked yet.
Vendor
Nexaph